Literature DB >> 26276515

Critical illness polyneuropathy and myopathy in a rural area in Vietnam.

Luan Nguyen The1, Cong Nguyen Huu2.   

Abstract

INTRODUCTION: Critical illness polyneuropathy, myopathy and polyneuromyopathy, grouped under the term CIP/CIM, share several risk factors and are associated with debilitating outcomes.
OBJECTIVE: To assess the incidence and distribution of CIP/CIM subtypes and evaluate the risk factors and outcomes of CIP/CIM in a rural hospital in Vietnam.
METHOD: One hundred and thirty three critically ill patients treated more than ten days in the ICU were enrolled. The Medical Research Council (MRC) sum scores and the Overall Neuropathy Limitations Scale (ONLS) score were calculated and risk factors were monitored. Extensive electrodiagnostic investigations were performed to confirm the diagnosis of CIP/CIM.
RESULTS: CIP/CIM was diagnosed in 73 (55%) patients. The distribution of polyneuropathy, myopathy and polyneuromyopathy was 35 (48%), 16 (22%) and 22 (30%), respectively. Independent risk factors included systemic inflammatory response syndrome, shock, and electrolyte disturbances. Compared to patients without CIP/CIM, patients with CIP/CIM experienced a mortality rate of 49% vs. 30%, a length of stay in ICU of 20.3days vs. 14.3days, an ONLS score at day thirty of 4.2 vs. 1.3 and at day ninety of 2.7 vs. 1.8.
CONCLUSION: The study revealed that the diagnosis of CIP/CIM was associated with significantly poorer outcomes in comparison to controls.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Critical illness; Electrodiagnosis; Intensive care unit; Myopathy; Polyneuromyopathy; Polyneuropathy

Mesh:

Year:  2015        PMID: 26276515     DOI: 10.1016/j.jns.2015.08.005

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

Review 1.  Recovery and long term functional outcome in people with critical illness polyneuropathy and myopathy: a scoping review.

Authors:  Domenico Intiso; Antonello Marco Centra; Michelangelo Bartolo; Maria Teresa Gatta; Michele Gravina; Filomena Di Rienzo
Journal:  BMC Neurol       Date:  2022-02-11       Impact factor: 2.474

2.  Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis.

Authors:  Tao Yang; Zhiqiang Li; Li Jiang; Xiuming Xi
Journal:  Crit Care       Date:  2018-08-03       Impact factor: 9.097

3.  Aminoglycoside use and intensive care unit-acquired weakness: A systematic review and meta-analysis.

Authors:  Tao Yang; Zhi-Qiang Li; Hong-Liang Li; Jian-Xin Zhou; Guang-Qiang Chen
Journal:  PLoS One       Date:  2020-03-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.